Financial Data and Key Metrics Changes - Revenue increased sequentially by $817,000 to $18,700,000, but decreased by 13% compared to the prior year [7][18] - Gross profit rose by $1,800,000 from Q1 and $2,100,000 year over year, with gross margin expanding to 26.1% [7][19] - Adjusted EBITDA showed a loss of $335,000 for the quarter, which is a sequential improvement of $131,000 but fell short by $53,000 compared to the prior year [7][22] Business Line Data and Key Metrics Changes - The Tubular segment has been fully divested, with only the idle facility in Munhall remaining as a financial drag [4] - The company is now a pure play specialty chemical company, focusing on higher margin opportunities and operational efficiencies [5][10] Market Data and Key Metrics Changes - The broader chemical market has shown softness, with manufacturing activity remaining below expansion territory, impacting overall demand [18][19] - Despite a 29.6% year-over-year decline in volume, pricing actions have helped mitigate some of the impacts [20] Company Strategy and Development Direction - The company is focused on organic and inorganic growth, with a disciplined approach to capital allocation and share repurchases [6][22] - A significant increase in the selling project pipeline by $25,000,000 indicates a strong focus on higher value commercial engagements [12][30] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving adjusted EBITDA margins of 15% by targeting $120,000,000 to $130,000,000 in revenue [28] - The company aims to maintain momentum through disciplined execution and capital stewardship, with expectations for continued improvement in profitability [23][41] Other Important Information - The company ended Q2 with $60,500,000 in cash, no debt, and $13,400,000 available under its revolver, indicating a strong financial position [22] - The share buyback program is not linked to any equity compensation plan but reflects the belief in the company's undervaluation [32] Q&A Session Summary Question: What revenue number is contemplated for the 2030 adjusted EBITDA margin target? - Management is confident in reaching $120,000,000 to $130,000,000 in revenue within the existing asset base [28] Question: How should the near to intermediate term new business pipeline be quantified? - The selling project pipeline increased by $25,000,000, spread across various market segments, indicating a mix of product sales and custom manufacturing [30] Question: Has the executive management equity compensation plan been presented to the board? - The share buyback was based on the belief that the company is undervalued, not related to any equity program for senior leaders [32] Question: What catalysts are expected for a rerating of the company? - Growth is seen as the primary catalyst, with a focus on both organic and inorganic growth [38] Question: Is a return to profitability expected in the near term? - Management is targeting profitability, excluding the Munhall aspect, and is optimistic about achieving this [41] Question: Will the company consider acquisitions in the future? - The company is looking for smaller transactions that can demonstrate growth synergies before pursuing larger acquisitions [46][58] Question: What multiples are expected for potential acquisitions? - The company aims to acquire assets at a lower end of the 6 to 8 times EBITDA range, focusing on disciplined growth [56][60]